Adocia Seeks $200M From Eli Lilly For Alleged Confidentiality Breaches
LYON, France — A French biopharmaceutical company on Feb. 6 announced that it asserted additional claims in an arbitration commenced against Eli Lilly & Co. in relation to its alleged misappropriation...To view the full article, register now.
Already a subscriber? Click here to view full article